Ignite Creation Date:
2024-05-05 @ 11:32 PM
Last Modification Date:
2024-10-26 @ 10:35 AM
Study NCT ID:
NCT01356875
Status:
UNKNOWN
Last Update Posted:
2011-05-20
First Post:
2011-05-18
Brief Title:
Treatment of Myelodysplastic Syndromes Comparing HydralazineAc Valproic and Supportive Care in Patients Not Candidates Refractory andor Intolerant to Intensive Chemotherapy
Sponsor:
Organization:
Basque Health Service
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
42
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: